MALVERN, Pa., April 29, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2020 earnings on Wednesday, May 6 at...
BioTelemetry (NASDAQ:BEAT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Monday, Zacks.com reports. According to Zacks, “BioTelem
BioTelemetry, Inc. (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that its 2020
MALVERN, Pa., April 27, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery...
Joe Capper became the CEO of BioTelemetry, Inc. (NASDAQ:BEAT) in 2010. This report will, first, examine the CEO...

Deutsche Bank Says Results Will Beat Forecasts

02:20am, Monday, 27'th Apr 2020
Deutsche Bank says results will beat forecasts
TLDR: 'Supernatural' will make you want to work out often.

Stocks Slip Again on Oil Prices

01:15pm, Wednesday, 22'nd Apr 2020
Stocks Slip Again on Oil Prices
BioTelemetry (BEAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
BioTelemetry (BEAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
BioTelemetry Inc (NASDAQ:BEAT) was the recipient of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 2,240,000 shares, a decrease of 16.6%
Nuveen Asset Management LLC trimmed its holdings in BioTelemetry Inc (NASDAQ:BEAT) by 0.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchang
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE